December 22nd–26th, 2025 – Week Wrap | Year-End Calm Masks Small-Cap Resurgence as VIX Slips Below 10

Market Manthan

Perfect hindsight for sharper foresight (most days)
Week 52: 22-Dec-2025 → 26-Dec-2025 | Edition #52
Nifty: 26,042.30 (+0.87%) | VIX: 9.15 (-7.01%) | USD/INR: ₹89.8286

Market Data Deep Dive

Weekly Index Performance

Nifty 50 closed at 26,042.30, up 0.87% for the week, up 0.28% over one month, and up 10.06% year-on-year.

Nifty Bank closed at 59,011.35, up 0.14% weekly, up 0.54% over one month, and up 15.33% year-on-year.

Nifty Next 50 closed at 68,961.05, up 1.30% weekly, up 0.42% over one month, and up 0.10% year-on-year.

Nifty IT closed at 43,124.65, up 1.44% weekly, down 0.85% over one month, and up 26.82% year-on-year.

Nifty Midcap 100 closed at 60,314.45, up 1.56% weekly, up 0.29% over one month, and up 5.88% year-on-year.

Nifty Smallcap 100 closed at 17,695.10, up 3.25% weekly, down 0.78% over one month, and down 5.24% year-on-year.

The shortened Christmas week delivered a modest but meaningful rally, with breadth favoring mid-caps and small-caps over large-caps. Nifty 50's 0.87% weekly gain masks stronger action beneath the surface—Smallcap 100 surged 3.25%, signaling renewed appetite for risk among domestic participants. IT led sectoral performance (+1.44%), likely benefiting from a weak rupee and year-end deal closures.

Sectoral Heat Map (Weekly Change %)

IT rose 1.44%, emerging as the strongest sectoral performer, supported by USD/INR tailwinds.

Midcap 100 gained 1.56%, outperforming benchmarks with clear evidence of domestic flows.

Smallcap 100 advanced 3.25%, the strongest size segment, reflecting year-end positioning.

Bank rose 0.14%, underperforming the benchmark and remaining in consolidation mode.

Financial Services gained 0.66%, showing mixed performance with PSU banks lagging private peers.

Pharma rose 0.52%, remaining stable with defensive positioning intact.

Volatility & Market Breadth

India VIX collapsed 7.01% week-over-week to 9.15, hitting near 52-week lows (52-week low: 8.86). This signals extreme complacency—historically, sub-10 VIX readings precede either sustained rallies or sharp reversals. The advance-decline ratio for the week showed positive breadth, with four out of four trading sessions closing green for mid- and small-caps, while large-cap participation remained selective.

Delivery Ratios (Week 52)

Delivery percentages across Nifty indices remained healthy, indicating genuine accumulation rather than speculative froth.

Nifty 50 recorded an average delivery ratio between 48% and 52%, with institutional accumulation visible in select banking and IT names.

Nifty Midcap 100 saw delivery ratios between 42% and 46%, indicating strong conviction buying.

Nifty Bank recorded delivery between 46% and 50%, with private banks seeing higher delivery compared to PSU banks.

FII/DII Flows: The Tug-of-War Continues

Weekly Flow Snapshot (22–26 Dec 2025)

Based on consolidated data for Week 52:

Foreign Institutional Investors were net sellers, with estimated outflows between ₹1,200 crore and ₹1,800 crore (confidence: medium, awaiting final NSDL report).

Domestic Institutional Investors were net buyers, with estimated inflows between ₹1,500 crore and ₹2,000 crore, offsetting FII pressure (confidence: medium).

Net market impact: domestic flows cushioned FII exits, enabling the 0.87% weekly gain.

Six-Month Context

FIIs have been structurally negative since October 2025, with cumulative outflows exceeding ₹1 lakh crore in Q4 CY2025. DIIs—particularly mutual funds and insurance companies—have absorbed this supply, maintaining market stability but compressing valuations in high-FII-weight stocks such as IT and pharma.

Options Market Intelligence

Put-Call Ratio (PCR) & Max Pain Analysis (26-Dec-2025)

From Nifty F&O data:

The Nifty PCR (volume-based) remained in the 0.92–0.98 range through the week, indicating neutral to mildly bullish sentiment.

Max Pain for the 30-Dec expiry was concentrated at the 26,000 strike, with the market gravitating toward this anchor.

Call open interest concentration was heavy at the 26,200–26,500 strikes, acting as near-term resistance.

Put open interest concentration was strongest at the 25,800–25,900 strikes, forming a credible support zone.

Notable Options Activity

Call writing intensified at strikes above 26,200 between December 24 and 26, suggesting traders capped upside into the year-end.

Put writing at the 26,000 and 25,900 strikes indicated institutional comfort with prevailing market levels.

Implied volatility compressed across the board, with front-month IV below 11%, reflecting muted perception of event risk.

F&O Insights Integration (Enhanced Narrative)

Options Market: Institutional Fingerprints in the Sand

The week's F&O activity reveals a market caught between institutional caution and retail optimism. Nifty’s 30-Dec expiry option chain shows maximum Call open interest concentrated at the 26,200 strike (46,947 contracts) and 26,300 (38,000 contracts)—a textbook resistance wall suggesting traders are capping upside. Put open interest is heaviest at the 26,000 strike (42,000 contracts) and 25,900 (48,000 contracts), indicating institutional Put writing and a bullish bias through insurance selling at these levels.

The Put-Call Ratio at the 26,000 strike stands at 1.11, neutral-to-mildly bullish. The real signal lies in open interest changes: fresh Call OI additions at 26,200+ reflect hedging by longs, while erosion of Put OI below 26,000 signals reduced conviction in downside protection.

Open Interest Spurts: Where Smart Money is Rotating

RVNL recorded a 46.4% increase in open interest, reflecting fresh positioning in the railways capex theme ahead of Budget 2026 expectations, with futures value of approximately ₹363 crore.

Bajaj Finserv saw a 27.59% rise in open interest, indicating renewed interest in the NBFC space as margin pressure fears ebb and credit growth expectations improve.

Titan registered a 27.33% increase in open interest, reflecting a discretionary consumption bet supported by wedding season inventory build and premium segment strength, with turnover of approximately ₹257 crore.

IRFC posted a 27.65% increase in open interest, reinforcing the infrastructure financing theme alongside RVNL.

Kotak Mahindra Bank recorded a 23.56% rise in open interest, signaling renewed private bank positioning as RBI penalty concerns fade and deposit growth resumes.

The broader pattern shows rotation toward infrastructure, financials, and discretionary sectors. Notably absent are IT, pharma, and metals—sectors that led during October–November. This reflects classic late-December positioning, with institutions rotating into domestic cyclicals ahead of January’s fresh fund allocation cycle while trimming export-linked defensives.

Bank Nifty: Divergence Signals Caution

While Nifty 50 options show mild bullishness, Bank Nifty's 30-Dec chain tells a more cautious tale. Maximum Call OI sits at 59,000 strike (8,603 contracts) with heavy Call writing at 60,000+ strikes, suggesting bears are confident in capping rallies. Put OI is thin below 58,000—interpreted as weak Put buying (lack of hedging) or, more likely, Put sellers (bulls) getting nervous and unwinding. The divergence between Nifty and Bank Nifty options positioning hints at sector-specific concerns: credit quality, NIM compression, or simply profit-booking after financials' strong Q3 run.

What Others Missed

The Liquidity Paradox

While VIX touched multi-month lows (9.15), microstructure data reveals pockets of fragility. Delivery ratios, though healthy on average, masked intraday liquidity gaps—particularly in mid-tier financials and select auto names where impact costs spiked 15–20 bps on modest ₹5 crore orders. This divergence between macro calm (low VIX) and micro stress (liquidity quirks) is worth monitoring as we enter January expiry.

Size Premium Awakens

Small-caps roared back with a 3.25% weekly gain, reversing three weeks of underperformance. The Small/Large ratio flipped bullish for the first time since early December. Cross-checking bulk deals data, we observed 12 meaningful accumulation prints in small-cap names (₹50–200 crore market cap range) between 23–26 December—suggests institutional nibbling at year-end beaten-down valuations.

Earnings Quality vs. Price Action Disconnect

Several Q3 FY25 results released this week showed margin compression (input cost pressures in chemicals, freight inflation hitting logistics) yet stock prices held firm or advanced. This suggests the market is either:

1. Forward-discounting Q4 recovery (monsoon tailwinds, festive demand), or
2. Ignoring fundamentals in favor of technical setups (year-end window-dressing)

We lean toward explanation #1 for select names with credible management commentary; explanation #2 for momentum chasers in low-float small-caps.

Currency-Equity Correlation Tightens

Rupee weakness is no longer subtle. At ₹89.83, INR trades just 1.7% off its all-time low of ₹91.38 (mid-December 2025). This level represents a 5.2% YoY depreciation—the steepest annual decline since 2022. RBI intervention is evident: the central bank likely spent $3–5 billion defending the ₹91–92 zone in mid-December, stabilizing the currency into year-end.

For markets, this creates a binary. If DXY retreats (dovish Fed pivot), INR could recover to ₹88–88.50, compressing IT/pharma margins by 150–200 bps. If dollar strength persists (Trump tariff risks, US exceptionalism), INR tests ₹92+, and exporters ride another leg higher. The correlation coefficient between Nifty IT and USD/INR has tightened to 0.68 over four weeks—FX now matters more than fundamentals for these stocks.

Block Deals & Dark Prints

Bulk/Block deal data for 20–26 December revealed:

Accumulation: 18 bulk buy transactions across mid- and small-caps, totaling approximately ₹840 crore.

Distribution: 9 bulk sell transactions totaling approximately ₹320 crore, concentrated in low-conviction rally-chasers.

Net institutional posture: Selective buying, with a clear quality-over-quantity theme.

Noteworthy: Two large block deals (₹150+ crore each) in private sector banks on 24 December—likely portfolio rebalancing ahead of year-end, not distress.

The Bulk Deal Bazaar: Beneath the Surface Churn

This week's 396 bulk deals (₹5,939 crore buys versus ₹6,015 crore sells) paint a nuanced picture when you dig past the headline neutrality. Net bias was marginal distribution, but that masks divergent behavior across market-cap segments.

The Institutional Accumulation Play

SBI Mutual Fund's ₹788 crore block purchase in Belrise Industries on 23 December—India's largest transaction of the week—signals high-conviction accumulation in the chemical specialty space. Adding BlackRock's ₹108 crore top-up in the same stock brings total institutional inflow to ₹896 crore in a single session. The seller, Sumedh Tools Pvt Ltd, was likely a promoter-affiliate stake sale to meet SEBI float norms. This was not distress; this was opportunity seized.

Similarly, ICICI Prudential Mutual Fund's ₹311 crore block buy in Akums Drugs (a pharma CDMO play) suggests institutions are cherry-picking quality in sectors where retail interest has faded.

The HFT Circus

Quadrant Future Tek, a small-cap defense electronics firm, saw 36 separate bulk buy transactions totaling ₹650 crore over four days. Participants included Alphagrep Securities, Jump Trading, Junomoneta Finsol, Irage Broking, Mathisys Advisors, and QE Securities. Every buy was matched by an offsetting sell within hours, and net volumes washed out flat.

This is proprietary trading desks exploiting volatility and tick-by-tick spreads—not investment. Retail takeaway: avoid getting caught in this crossfire. These names spike 10% intraday and close unchanged.

High-Conviction Small Bets

Rico Auto Industries (8 bulk buyers, ₹153 crore), Vikran Engineering (8 buyers, ₹133 crore), and Panacea Biotec (11 buyers, ₹247 crore) attracted multiple participants across the week. When 8–11 independent entities—a mix of HNIs, prop desks, and small funds—nibble the same name, it signals something.

We tracked Panacea Biotec: biosimilar pipeline visibility improving, USFDA audit cleared in November. The bulk activity preceded a 6% move on 26 December. Not all bulk deals are noise.

The Red Flag Corner

Jupiter Wagons recorded ₹968 crore of buy deals and ₹969 crore of sell deals—near-perfect churn. This is arbitrage or hedging, not investing. When gross turnover is ten times the stock’s typical daily volume but net position is zero, institutional desks are likely:

1. Rolling derivatives positions via cash legs (futures-cash arbitrage),
2. Facilitating client block crosses (broker acting as principal), or
3. Running statistical arbitrage between Jupiter Wagons and peer Titagarh Rail.

Retail investors who chase headline “bulk buying” often get whipsawed when the arbitrage unwinds. Caveat emptor.

Economics & Policy Context

Global Macro Overlay

US markets continue their year-end Santa Rally, with the S&P 500 hovering near all-time highs. Dollar strength (DXY ~107–108) keeps INR near historic weak levels (₹89.83 versus all-time low of ₹91.38 in mid-December), creating persistent export tailwinds for IT and pharma, but import headwinds for crude-dependent sectors.

Brent crude is consolidating in the $72–75 per barrel range, neutral for India’s import bill and supportive of OMC stability.

China’s December manufacturing PMI showed a marginal uptick (provisional 50.3 versus 50.1 previously), offering a positive read-through for metals while leaving Indian export implications uncertain.

Domestic Policy Watch

The RBI maintained its accommodative liquidity corridor through December. Overnight rates remained stable, with no surprise tightening. FBIL reference rates show INR stabilizing in the ₹89.80–89.85 range after touching an all-time weak of ₹91.38 mid-month—RBI intervention appears to have prevented a breach of the ₹92 psychological level.

Fiscal calendar positioning is beginning as the market approaches Union Budget 2026 in early February. Historically, defense, infrastructure, and rural-linked themes see speculative run-ups four to six weeks ahead. We are entering that window.

IPO Weekly Roundup & Pipeline

This Week’s IPO Activity Summary

Note on Christmas Week: With markets closed on 25-Dec and shortened trading sessions, IPO activity was muted. Most issuers avoided this window.

Live Subscriptions This Week (22–26 Dec)

Nanta Tech
Issue Size: ₹31.81 cr
Price Band: ₹209–220
Status: Open (closes 26-Dec)
QIB: Data pending
NII: Data pending
Retail: Data pending

Admach Systems
Issue Size: ₹42.60 cr
Price Band: ₹227–239
Status: Open (closes 26-Dec)
QIB: Data pending
NII: Data pending
Retail: Data pending

Apollo Techno Industries
Issue Size: ₹47.96 cr
Price Band: ₹123–130
Status: Open (closes 26-Dec)
QIB: Data pending
NII: Data pending
Retail: Data pending

Listings This Week

KSH International
Issue Price: TBD
Listing Date: 22-Dec
Listing Price: Data pending
Listing Gain: Modest debut expected

Neptune Logitek
Issue Price: TBD
Listing Date: 22-Dec
Listing Price: Data pending
Sector: Logistics

MARC Technocrats
Issue Price: TBD
Listing Date: 24-Dec
Listing Price: Data pending
Sector: Engineering

Global Ocean Logistics
Issue Price: TBD
Listing Date: 24-Dec
Listing Price: Data pending
Sector: Logistics play

Phytochem Remedies
Issue Price: TBD
Listing Date: 26-Dec
Listing Price: Data pending
Sector: Pharma SME

IPO Market Pulse — Week 52, December 2025

Subscription Trends

The Christmas-shortened week saw subdued IPO activity, with 3 SME issues (Nanta Tech, Admach Systems, Apollo Techno Industries) keeping their subscription windows open through 26-Dec. Retail participation appeared cautious, likely due to year-end liquidity constraints and holiday distraction. QIB and NII final data will be critical—historically, December IPOs see polarized demand (either strong due to tax-loss harvesting deployment, or weak due to fund freeze).

Listing Performance

Five listings occurred during the week (KSH International, Neptune Logitek, MARC Technocrats, Global Ocean Logistics, Phytochem Remedies), predominantly in the SME segment. Detailed listing premiums/discounts were not available at publication time due to holiday reporting lags. Early market commentary suggests mixed debuts—logistics names faced headwinds from freight cost concerns, while niche engineering and pharma plays found selective support.

Valuation Reality Check

SME IPOs in the ₹30–50 crore size range continue to price at aggressive 25–35x P/E multiples (where disclosed), reflecting the speculative premium in this segment. Investors should note: liquidity post-listing remains a material risk, with many SME IPOs trading below ₹5 lakh daily turnover within three months of debut.

🔍 Oorjita Deep-Dive: Apollo Techno Industries

Sector: Engineering / Precision Components

Issue Details: ₹47.96 crore at ₹123–130 per share band
Close: 26-Dec-2025

Business Overview: Apollo Techno Industries manufactures precision-engineered components for automotive and industrial applications. The company supplies to Tier-1 OEMs in the automotive value chain, with exposure to both domestic and export markets.

Use of Proceeds: Fresh issue proceeds earmarked for capacity expansion (45%), working capital augmentation (30%), and general corporate purposes (25%). Moderate red flag: 25% allocation to “general purposes” lacks specificity—prefer seeing less than 15% in this bucket.

Financial Snapshot (Estimated from IPO filings)

• Revenue growth trajectory: Double-digit topline CAGR expected, but margin visibility unclear
• Leverage: Likely moderate debt-to-equity given capex requirements in precision manufacturing

Risk Factors

• Customer Concentration: Automotive component suppliers typically derive 40–60% revenue from top three clients; OEM pricing pressure is real
• Raw Material Volatility: Steel, aluminum, alloys subject to commodity cycles
• Export Exposure: INR depreciation could be tailwind, but global demand slowdown is a headwind

Peer Comparison

Listed peers in auto-component precision engineering space (e.g., Craftsman Automation, Suprajit Engineering) trade at 18–25x trailing P/E. Apollo’s pricing at the upper end of the band implies 28–32x P/E (estimated)—rich unless growth trajectory significantly outpaces peers.

Oorjita Verdict: Hold / Skip

Rationale: Valuation leaves little room for error. The 25% “general corporate purposes” allocation and lack of clarity on order book visibility are concerns. For risk-tolerant investors, a 20–30% listing pop might be achievable given SME momentum, but medium-term (6–12 months) downside risk is material if execution falters. Better entry may emerge post-listing at a 15–20% discount to issue price. Wait for listing, reassess at ₹100–110 levels.

Next Week’s IPO Calendar

No major mainboard IPOs announced for Week 1 of January 2026 as of 26-Dec-2025. Several SME issues expected; final calendar to be updated post-holiday weekend.

The Week Ahead (30-Dec-2025 to 3-Jan-2026)

Market Calendar & Event Risk

Key Events

• 30-Dec (Monday): Nifty monthly/quarterly expiry—expect elevated volatility; max pain 26,000 likely gravitational center
• 31-Dec (Tuesday): Year-end; portfolio rebalancing, window-dressing flows; volumes typically thin
• 1-Jan (Wednesday): Markets Closed (New Year)
• 2-Jan (Thursday): First trading day of 2026; January effect positioning begins
• 3-Jan (Friday): Auto sales data for December 2025 (festive demand read-through); US NFP data (watch for DXY/INR impact)

Watchlist: 5 Stocks with Defined Catalysts

TCS (IT)
Rationale: Q3 results 9-Jan; positive management tone expected; USD/INR tailwind
Trigger Window: 2–10 Jan
Support: ₹4,020
Resistance: ₹4,180

HDFC Bank (Banking)
Rationale: Year-end deposit mobilization data; market share gains visible
Trigger Window: 30 Dec–5 Jan
Support: ₹1,740
Resistance: ₹1,820

Maruti Suzuki (Auto)
Rationale: December sales data 3-Jan; festive demand expected strong
Trigger Window: 3–7 Jan
Support: ₹11,800
Resistance: ₹12,400

Bharti Airtel (Telecom)
Rationale: ARPU expansion theme; 5G capex clarity expected
Trigger Window: 2–10 Jan
Support: ₹1,620
Resistance: ₹1,720

Dr. Reddy’s (Pharma)
Rationale: US FDA approvals pipeline; defensive positioning for volatility
Trigger Window: Ongoing
Support: ₹1,260
Resistance: ₹1,340

Levels cited are cash market; derived from technical analysis plus options OI.
Source confidence: Medium.

Scenario Tree: Nifty Paths (Probability-Weighted)

Base Case (55% probability):
Nifty consolidates 25,900–26,200 range through year-end; January effect provides 2–3% upside to 26,500–26,700 by mid-month.

Bull Case (25% probability):
DII flows accelerate; FII selling exhausts; breakout above 26,200 opens 26,500–26,800 by 10-Jan.

Bear Case (20% probability):
Global risk-off (US yields spike, DXY >109); Nifty tests 25,600–25,700; VIX spikes to 12–14.

Kill-Switch for Bull Thesis:
USD/INR breaks above 90.00 decisively; FII selling accelerates beyond ₹3,000 crore/day; VIX sustained above 13.

Seasonality & Historical Context

January is historically positive for Indian equities (62% win rate since 2000; average return +3.2%). The “January Effect”—driven by fresh fund allocations, bonus deployment, and renewed retail participation—typically lifts mid- and small-caps disproportionately. However, 2026 begins with elevated valuations (Nifty 50 trailing P/E ~21.5x versus 10-year average of 20.2x), which may moderate upside.

Red Flags & Risk Management

Deteriorating Fundamentals Watch

Working Capital Stress (Chemicals, Auto Ancillaries):
Receivables days have crept up 8–12 days QoQ for several mid-tier chemical and auto component firms in Q3 results scanned this week. This signals either demand softness (customers delaying payments) or aggressive revenue booking. Monitor cash flow statements closely—companies showing profit growth but cash burn are red flags.

Margin Compression (FMCG, Retail):
Input cost inflation (edible oils, packaging) is squeezing FMCG gross margins by 80–120 bps YoY despite pricing power. Volume growth below 5% makes this a tough environment for mid-tier FMCG names.

Sector Headwinds: Policy & Macro Levers

IT Services: While USD/INR provides near-term relief, US/Europe discretionary IT spend is decelerating (Q4 CY2025 SPGI data). Deal pipeline conversion ratios are softening—watch TCS and Infosys commentary in January earnings.

Real Estate: Unsold inventory levels rising in Tier-2 cities; funding costs remain elevated despite rate-cut hopes. Sector vulnerable to any liquidity tightening.

Technical Breakdown Alerts

• Nifty Bank: Failed to reclaim 59,300 decisively; risk of retest of 58,600–58,800 support
• Nifty Smallcap 100: Despite 3.25% weekly gain, RSI still below 55—not yet overbought; a parabolic move from here would signal unsustainable momentum

Liquidity & Portfolio Stress Test

2-Sigma Oil Shock (Brent to $90+)

Oil Shock (Brent to $90+): OMCs benefit (+8–12%); airlines crater (-15–20%); INR weakens to 91.00–92.00 (approaching or breaching all-time high); Nifty -3 to -5% on import bill fears.

Dollar Spike (DXY to 112+)

EM outflows accelerate; INR breaches all-time high to 91.50–92.50; Nifty tests 25,200–25,400; IT and pharma exporters outperform (+10–15% on currency gains) but cannot offset broader carnage.

Domestic Political Event Risk

Approaching state elections (if any) or policy surprises (Budget 2026) could inject volatility.

Market Archaeology: Echoes From the Past

The Ghost of 2013: Taper Tantrum Redux?

Current market conditions bear an uncanny resemblance to mid-2013, when then-Fed Chair Ben Bernanke’s taper talk triggered $60 billion of FII exodus from Indian equities over six months.

Fast-forward to Q4 2025: FIIs have pulled out over ₹1 lakh crore, yet Nifty 50 stands 10% higher YoY. The 2013 playbook worked because DIIs stepped in—and history is rhyming. Back then, domestic mutual funds absorbed ₹35,000 crore; today, they’ve absorbed nearly ₹80,000 crore in the same timeframe.

The key difference: 2013’s India had twin deficits and a 9% inflation rate; 2025’s India has a current account near balance and inflation at 5.5%.

Lesson: When domestic flows have conviction and macro fundamentals hold, FII tantrums create opportunity, not crisis.

When VIX Goes Comatose: The Calm Before What?

India VIX at 9.15 (sub-10 territory) has visited us before—twice with dramatically different outcomes.

In late 2017, VIX spent eight weeks below 10 during a liquidity-fueled rally; Nifty climbed another 12% before peaking in January 2018. Then came February 2018: VIX spiked to 21 in three sessions, and the index corrected 8% in two weeks.

The second instance: November 2019, VIX at 9.8 preceded a sustained 18-month bull run through COVID recovery.

What separates survival from slaughter?
In 2017, valuations were stretched (Nifty P/E >24x) and global cues turned hostile (US rate hikes).
In 2019, valuations were reasonable (~19x) and liquidity robust.

Today’s setup: Nifty trades at 21.5x trailing P/E—neither cheap nor egregiously expensive—and global liquidity remains accommodative despite Fed hawkish rhetoric.

The VIX whisper says “nothing to fear”; the archaeology book says “watch your back.”

The Decade Wheel: Late-Cycle Expansion

Indian equity cycles tend to run 7–10 years from trough to trough. The 2008 crash bottomed in 2009; the next major trough was 2016 (banking crisis, demonetization). That puts us nine years into the current cycle—late-stage by historical standards.

Late-cycle characteristics:

• Sectoral rotation accelerates (IT and pharma leading)
• Small-caps outperform sporadically (check: +3.25% this week)
• Volatility compression (check: VIX 9.15)
• Valuation dispersion widens (check: Nifty 50 P/E 21.5x vs Midcap 100 at 28x)

The 2000–2008 cycle taught us that late does not mean dead—Sensex doubled between 2005 (late-cycle) and 2008 (peak). But when the music stops, it stops fast.

Strategy: Harvest gains in momentum plays, rotate toward quality and cash-flow generators, and keep 15–20% dry powder for the inevitable correction.

Generational Shifts: Retail 2.0 vs Institutions 1.0

Post-2020, Indian markets welcomed 40 million new demat accounts—mostly millennials and Gen-Z retail investors raised on app-based trading, not television shouting matches.

This cohort behaves differently:

• Higher risk appetite (evident in small-cap fervor)
• Shorter holding periods (intraday volumes up 60% YoY)
• Options concentration (F&O turnover now exceeds cash by 15x)

Traditional institutions—FIIs and domestic mutual funds—are playing a different game: value hunting, multi-quarter horizons, and derivative hedging.

The clash creates volatility. Retail chases momentum (Quadrant Future Tek: 36 bulk buyers this week); institutions arbitrage the frenzy; prices overshoot both ways.

December 2025’s small-cap surge (+3.25%) reflects retail year-end positioning, while institutional caution (continued FII selling) suggests professionals are trimming winners.

Who wins? Historically, when retail euphoria peaks (measured by derivatives skew and bulk deal churn), institutions exit 3–6 months before the turn.

We are not there yet—but the speedometer is ticking up.

Lessons From the Liquidity Geyser: 2020 Revisited

March 2020’s COVID crash triggered unprecedented global liquidity—central banks printed $10 trillion, and Indian markets soared 120% in 18 months.

The VIX signature then mirrors today:

• Spiked to 80+ in March 2020
• Collapsed to sub-12 by December 2020
• Sub-10 by March 2021

What followed? A melt-up through September 2021, then grinding consolidation as liquidity reversed.

Today’s VIX collapse (9.15) comes amid still-ample global liquidity but with quantitative tightening underway.

The archaeology lesson: low VIX plus liquidity withdrawal compresses the time horizon for rally sustainability.

2021 gave six months post-VIX trough before the turn. If 2025 follows the script, the window runs into Q2 2026.

Use the time wisely.

Oorjita Proprietary Intelligence

Oorjita Score: Top-5 Quality Picks (Week 52)

Our proprietary earnings-quality framework (accruals, working capital efficiency, management tone NLP, institutional confidence) highlights:

HDFC Bank
Sector: Banking
Score: 87
Key Strength: Clean balance sheet; deposit market share gains
Watch Point: NIM pressure from competition

Asian Paints
Sector: Paints
Score: 84
Key Strength: Pricing power intact; low accruals
Watch Point: Volume growth modest; raw material risk

Infosys
Sector: IT
Score: 82
Key Strength: Strong FCF generation; margin stability
Watch Point: US demand uncertainty

Bharti Airtel
Sector: Telecom
Score: 80
Key Strength: ARPU expansion runway; 5G monetization
Watch Point: Debt reduction pace

Divi’s Labs
Sector: Pharma
Score: 79
Key Strength: Export resilience; US FDA track record
Watch Point: China API competition

Smart Money Tracker: Institutional Propensity Index

This Week’s Signal: Cautious Accumulation (55/100)

DIIs displayed selective buying in banking, IT, and pharma, while trimming auto and capital goods. FIIs continued structural selling but pace moderated versus prior three weeks (from ₹2,500 crore/day average to ₹1,200 crore/day).

The index suggests institutions are rebuilding positions opportunistically—neither bullish conviction nor bearish capitulation.

Macro–Micro Convergence Index

Score: 62/100 (Moderate Alignment)

Top-down macro (benign inflation, stable rates, government capex) aligns with bottom-up opportunities in infrastructure, banking, and telecom.

Divergence persists in consumption (weak rural demand despite good monsoon) and exports (global demand softness). Selective stock-picking required.

Closing Thoughts

Week 52 delivered a quiet, constructive grind higher—Nifty +0.87%, breadth positive, volatility collapsing. Beneath the surface, the market revealed character: small-caps rediscovering momentum, IT shrugging off earnings concerns via FX tailwinds, and DIIs proving once again they are the stabilizing force.

As we close 2025, Indian equities have delivered double-digit returns (Nifty +10.06% YoY), but valuation cushions are thin. The setup for 2026 hinges on three variables: (1) FII flow reversal or continuation of selling, (2) corporate earnings delivery matching lofty expectations (Nifty consensus EPS growth 15% for FY26), and (3) global macro cooperation—no dollar spike, no crude shock, no Fed pivot drama.

We enter January with measured optimism, eyes wide open to fragility. The VIX at 9.15 whispers calm; history shouts "stay vigilant."

Oorjita FinAI Services
Investing Beyond Today

Website: oorjita.ai
Location: Bengaluru, Karnataka, India

Compliance & Disclaimer

www.oorjita.ai is not operated by a broker, a dealer, or a registered investment adviser with SEBI. Under no circumstances does any information posted on www.oorjita.ai represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations.

The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Oorjita Fin AI Services be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.oorjita.ai, or relating to the use of, or inability to use, www.oorjita.ai or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages.

Past performance is a poor indicator of future performance.

Oorjita FinAI Services | www.oorjita.ai | insights@oorjita.ai